HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 444, 94-104
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2018R1A2A1A05077263, 2014M3C1A3051476, 2014009392)
- Institute for Basic Science (IBS-R010-G1)
- Korea Health Technology R&D project (HI15C0554)
- Ministry of Health and Welfare
This publication has 41 references indexed in Scilit:
- Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cellsCancer Letters, 2013
- Akt Regulates TNFα Synthesis Downstream of RIP1 Kinase Activation during NecroptosisPLOS ONE, 2013
- Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR InhibitionPLOS ONE, 2012
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- Programmed necrosis: backup to and competitor with apoptosis in the immune systemNature Immunology, 2011
- Many stimuli pull the necrotic trigger, an overviewCell Death & Differentiation, 2011
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to NecrosisScience, 2009
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-αCell, 2009
- Carboxypeptidase H in bovine pituitary gland: Soluble forms are not processed at the C-terminusMolecular and Cellular Endocrinology, 1992